Pharmaceutical contract

Astron Research Ltd

Astron Research Limited is a fast growing Pharma Contract Research Organisation (CRO) with a strong quest to deliver best services to the rapidly growing Healthcare industry and has embarked its presence as a prominent global CRO. The Company was established in the year 2001 with an objective to provide prompt and reliable services to Pharma sector worldwide and improve the product quality with the help of Technological Innovations and Upgradations. Astron commenced its UK operations in 2004 for Quality Testing and QP Release of finished formulations and API. This facility is now UK-MHRA approved. The Company has products and technology are sold in over 50 countries, which includes European Union, US, Canada Australia, New Zealand, South Africa, Brazil, Mexico, Middle East & North African countries. 13 ANDAs filed in US and 30 Dossiers completed in EU CTD, by now. The Global turnover registered a growth of 40% in the current financial year with the contribution of European market being 50%. The company is capable of handling Formulation and Analytical Research of Solid Orals, Injectables, Lyophilised injectables, Topicals, Effervescent tablets, Specialty medicaments like Potent drugs & Oncology products. The company has also acquired expertise in oral NDDS and Controlled Release pellets. The Company has around 170 Research Professionals working on various drug products and the departments of work force include: Research & Development Project Co-ordination Regulatory Support Business Development Market support & Customer service Liaisons and Logistics

12/8/2013
4
0

NAEJA Pharmaceutical Inc

http://www.naeja.com

NAEJA was established in 1999 with a rollover of assets, including staff, equipment and intellectual property, from SynPhar Laboratories Inc. and research contracts from DrisCorp Inc. What began as a full fledged pharmaceutical company with an extensive intellectual property portfolio and a proven track record has evolved into an internationally respected pharmaceutical outsource service provider. NAEJA has carved a unique niche in the outsource industry offering extensive discovery experience and expertise. The flexibility NAEJA offers to custom design drug discovery services has kept NAEJA at the forefront of the industry. NAEJA's commitment to global health, extensive drug discovery experience and attention to continual improvement are key factors that contribute to NAEJA's success and keep the company at the forefront of the industry. NAEJA will continue to focus on delivering optimum service in a continued commitment to the pharmaceutical industry. It is through international teamwork that we must wage our war against illness and NAEJA will continue on with its mission making significant contributions as a valuable team member.

12/8/2013
4
0

Note

Not found any data